TNXP
Noble Capital Markets gives an Outperform recommendation for Tonix Pharmaceuticals Holding Corp (TNXP)
Tonix Pharmaceuticals Holding Corp’s recent filing unveils that its Director Taylor Carolyn E. acquired Company’s shares for reported $15061.0 on ...
0 analysts rank TNXP stock as an Overweight
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Tonix Pharmaceuticals ...
Noble Capital Markets analysts initates an Outperform rating for Tonix Pharmaceuticals Holding Corp (TNXP)
In a filing, Tonix Pharmaceuticals Holding Corp revealed its Director Taylor Carolyn E. acquired Company’s shares for reported $15061.0 on ...
Tonix Pharmaceuticals Holding Corp’s latest rating changes from various analysts
Tonix Pharmaceuticals Holding Corp’s recent filing unveils that its Director Taylor Carolyn E. acquired Company’s shares for reported $15061.0 on ...
Potential Price Increase for Tonix Pharmaceuticals Holding Corp (TNXP) After Recent Insider Activity
Tonix Pharmaceuticals Holding Corp’s filing revealed that its Director Taylor Carolyn E. acquired Company’s shares for reported $15061.0 on Aug ...
Investing in Tonix Pharmaceuticals Holding Corp (TNXP): What You Must Know
Tonix Pharmaceuticals Holding Corp’s filing revealed that its Director Taylor Carolyn E. acquired Company’s shares for reported $15061.0 on Aug ...
Tonix Pharmaceuticals Holding Corp [TNXP] Investment Guide: What You Need to Know
In a filing, Tonix Pharmaceuticals Holding Corp revealed its Director Taylor Carolyn E. acquired Company’s shares for reported $15061.0 on ...
